This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 26 | 116,411 | 830,689 | -36,000 | 0 | 100,000 | 100,000 | 100,000 | 116,411 | 608,524 | 1,675,692 | 1,738,402 | 2,499,448 | 2,543,453 |
| Global health | 25 | 116,411 | 794,381 | -36,000 | 0 | 50,000 | 100,000 | 100,000 | 116,411 | 574,999 | 999,990 | 1,711,524 | 2,499,448 | 2,543,453 |
| Nutrition | 1 | 1,738,402 | 1,738,402 | 1,738,402 | 1,738,402 | 1,738,402 | 1,738,402 | 1,738,402 | 1,738,402 | 1,738,402 | 1,738,402 | 1,738,402 | 1,738,402 | 1,738,402 |
| Donor | Total | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 21,597,921.66 | 3,118,452.00 | 5,894,354.00 | 688,935.00 | 4,761,670.00 | 100,000.00 | 3,123,564.66 | 999,859.00 | 2,611,087.00 | 200,000.00 | 100,000.00 |
| Total | 21,597,921.66 | 3,118,452.00 | 5,894,354.00 | 688,935.00 | 4,761,670.00 | 100,000.00 | 3,123,564.66 | 999,859.00 | 2,611,087.00 | 200,000.00 | 100,000.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 26) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 574,999.00 | 12 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to understand the epidemiology of childhood diseases in Ethiopia. Supporting childhood morbidity and mortality surveillance in Ethiopia. Investment start date: 9/6/2017 to end date: 5/31/2020. Grantee name: Children's Hospital Boston; Aid type: Project-type interventions. Affected countries: Ethiopia. | |
| Bill and Melinda Gates Foundation | 2,543,453.00 | 1 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to assess the effects of early biological and psychosocial adversity on neurocognitive development using a range of neuroimaging and behavioral assessment tools; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,675,692.00 | 8 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to understand the epidemiology of childhood diseases in Ethiopia. Supporting childhood morbidity and mortality surveillance in Ethiopia. Investment start date: 9/6/2017 to end date: 5/31/2020. Grantee name: Children's Hospital Boston; Aid type: Project-type interventions. Affected countries: Ethiopia. | |
| Bill and Melinda Gates Foundation | 2,507,138.00 | 2 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to contribute to efforts in developing an HIV-1 vaccine, which is urgently needed to combat the AIDS pandemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,711,524.00 | 7 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to assess the effects of early biological and psychosocial adversity on neurocognitive development using a range of neuroimaging and behavioral assessment tools; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -36,000.00 | 26 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a bivalent vaccine by conjugating a fusion of three novel, highly-conserved pneumococcal antigens to the already approved Vi polysaccharide vaccine used for typhoid; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 116,411.00 | 14 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to assess the effects of early biological and psychosocial adversity on neurocognitive development using a range of neuroimaging and behavioral assessment tools; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 608,524.00 | 11 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | To create immunogenic Multiple Antigen Presenting System complexes that generate antibody against Mycobacterium Tuberculosis surface lipids; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,062,222.00 | 5 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a bivalent vaccine by conjugating a fusion of three novel, highly-conserved pneumococcal antigens to the already approved Vi polysaccharide vaccine used for typhoid; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 15 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to identify children at high risk of developing cognitive impairments also in adulthood by developing a simple scoring system from existing epidemiological data that can be used on diverse populations and in low resource settings; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 15 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to enable non-invasive monitoring of prenatal brain development also in low-income countries by developing a method involving a dual array of magnetic sensors placed around the mother’s torso; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,499,448.00 | 3 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to assess the effects of early biological and psychosocial adversity on neurocognitive development using a range of neuroimaging and behavioral assessment tools; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 15 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to test novel technologies for developing more effective neonatal vaccines to improve infant health and survival, particularly in low income countries and the world's poorest communities; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 400,000.00 | 13 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | To produce cheap vaginal contraceptives, which are safer and more effective, by refining and testing an engineered nanoparticle contraceptive that blocks sperm motility required for fertilization using animal models.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,738,402.00 | 6 | Nutrition/basic nutrition | https://iatiregistry.org/publisher/bmgf | -- | to test whether known biomarkers of gut dysfunction can accurately predict impaired neurodevelopment and stunting, which reflects chronic malnutrition and is associated with increased morbidity and mortality in young children.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -7,413.67 | 24 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop a drug compliance platform that uses mobile phones to administer, read and submit a simple diagnostic test, resulting in economic incentives for the user, such as additional cell phone minutes; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -7,413.67 | 24 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop a drug compliance platform that uses mobile phones to administer, read and submit a simple diagnostic test, resulting in economic incentives for the user, such as additional cell phone minutes; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 999,990.00 | 9 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a bivalent vaccine by conjugating a fusion of three novel, highly-conserved pneumococcal antigens to the already approved Vi polysaccharide vaccine used for typhoid; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 999,859.00 | 10 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to determine safety and efficacy of topical candidate adjuvants, called imidazoquinolines, to enhance responses to pneumococcal vaccination; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 50,000.00 | 22 | Global health/Tuberculosis control | https://iatiregistry.org/publisher/bmgf | -- | to develop a drug compliance platform that uses mobile phones to administer, read and submit a simple diagnostic test, resulting in economic incentives for the user, such as additional cell phone minutes; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 50,000.00 | 22 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop a drug compliance platform that uses mobile phones to administer, read and submit a simple diagnostic test, resulting in economic incentives for the user, such as additional cell phone minutes; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 15 | Global health/Reproductive health care | https://iatiregistry.org/publisher/bmgf | -- | to develop and test a nanoparticle contraceptive that releases sperm tail inhibitors in response to vaginal pH changes or exposure to prostatic fluid; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,411,087.00 | 4 | Global health/Medical research | https://iatiregistry.org/publisher/bmgf | -- | to test novel technologies for developing more effective neonatal vaccines to improve infant health and survival, particularly in low income countries and the world's poorest communities; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 15 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to conjugate a fusion of three highly-conserved pneumococcal antigens to the already approved Vi polysaccharide vaccine used for typhus. Then test the vaccine's ability to induce strong immune responses against pneumococcus and typhoid fever.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 15 | Global health/basic health care | https://iatiregistry.org/publisher/bmgf | -- | to determine whether novel synthetic molecules (imidazoquinolines) are able to activate newborns white blood cells as candidate vaccine adjuvants to dramatically enhance immunization of infants.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 100,000.00 | 15 | Global health/Health policy and administrative management | https://iatiregistry.org/publisher/bmgf | -- | to engineer nanoparticles that mimic host cells in an attempt to deceive viruses into releasing genetic material which is rendered useless by viral inhibitors.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |